5 papers about lung cancer suggested by Stephen Liu

Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers on X:

RET rearrangements detection by FISH compared to other techniques in non-small cell lung cancer

Authors: A. Mc Leer, J. Mondet, N. Magnat, M. Mersch, D. Giovannini, C. Emprou, A.C. Toffart, N. Sturm, S. Lantuéjoul, D. Benito

Eftilagimod Alpha (a Soluble LAG-3 Protein) plus Pembrolizumab in Second-Line Metastatic Non-Small Cell Lung Cancer Refractory to Anti-PD-(L)1-based Therapy: Final Results from a Phase II Study

Authors: M.G. Krebs, M. Forster, M. Majem, J. Peguero, W. Iams, T. Clay, P. Roxburgh, B. Doger, P. Bajaj, B. Andres, S. Perera, C. Mueller, F. Triebel

Efficacy and safety of pralsetinib in patients with RET fusion positive non–small cell lung cancer: An observational real world study

Authors: Dehua Liao, Minghui Long, Jiwen Zhang, Xingyu Wei, Fei Li, Ting Yan, Desong Yang

Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update

Authors: Afshin Dowlati et al.

Real-World Biomarker Test Ordering Practices in Non–Small Cell Lung Cancer: Interphysician Variation and Association With Clinical Outcomes

Authors: Jason Baron, Sarrah Widatalla, Matthew Gubens, Farah Khalil

Follow Stephen Liu on X for more such content.

Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center.

As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer.

Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.